Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Ambetter Health Insurance lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all blog posts
2.15.2017

New Study Shows Link Between Talcum Powder Use and Ovarian Cancer

By Tim Jackson, Associate
Uncategorized

bottle of talcum powder

A study published in the European Journal of Cancer Prevention on January 11, 2017 found a small, but statistically significant, link between women’s talcum powder use and ovarian cancer. While there has been a growing body of literature regarding the association between talcum powder use and ovarian cancer, the evidence has not been consistent.

In the new study, researchers at the Tisch Cancer Institute of Mount Sinai Hospital sought to “formally evaluate this suspected association” by analyzing the data from over two dozen prior studies, including over 300,000 women with ovarian cancer. Regarding the risk of ovarian cancer, researchers noted: “Overall, it is about a 20 percent higher risk for women who say they used talc, compared to women to say they did not use it.”

However, while the findings of this study do suggest a statistically significant link between talcum powder use and ovarian cancer, the researchers have stressed that the results cannot prove how talcum powder causes cancer.

While there are several different sub-types of ovarian cancer, the researchers have pointed out that this study’s conclusions appear to be limited to only one type of ovarian cancer—serous carcinoma.

This study may be seen as good news for the thousands of ovarian cancer victims and their families who are pursuing talcum powder lawsuits against Johnson & Johnson. Plaintiffs allege that for decades, a growing number of studies have pointed to a link between genital talc use in woman and an increased risk of ovarian cancer. Women who were diagnosed with ovarian cancer following long-term, regular use of talc products for feminine hygiene purposes may be eligible for their own talcum powder lawsuit.

Photo: Austin Kirk

 

Share

No Comments

Leave a Reply Cancel reply

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.

Categories

  • Uncategorized
  • Columns
    • Guest Post
    • Ken Wexler
  • Hall Of Shame
    • Villain Of The Week
  • In The News
    • Public Victories
  • The Firm
    • Around The World
    • Chicago
  • You Should Know
    • For Businesses
    • For Consumers
    • For Investors
  • Media Appearances
  • Cases
  • Facebook
  • Twitter
  • LinkedIn
Image

55 W Monroe St. Suite 3300
Chicago, IL 60603
P_312.346.2222
F_312.346.0022

 

333 University Ave. Suite 200
Sacramento, CA 95825
P_916.565.7692
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP